Chapter

Risk estimation systems in clinical use: SCORE, HeartScore, Framingham, PROCAM, ASSIGN, and QRISK

Catherine McGorrian, Tora Leong, Ralph D'Agostino, Marie-Therese Coney and Ian M. Graham

in Hyperlipidaemia

Published on behalf of Oxford University Press

ISBN: 9780199543502
Published online October 2011 | e-ISBN: 9780199607204 | DOI: http://dx.doi.org/10.1093/med/9780199543502.003.0003

Series: Oxford Cardiology Library

Risk estimation systems in clinical use: SCORE, HeartScore, Framingham, PROCAM, ASSIGN, and QRISK

Show Summary Details

Preview

• Atherosclerosis underlying cardiovascular disease (CVD) is a multifactorial disease; hence, global risk estimation is necessary for making clinical decisions. • Individuals with serious inherited lipid disorders, for example, those with familial hypercholesterolaemia are at high risk and need intensive lipid management and attention to other risk factors. • Individuals with established CVD have declared themselves to be at high risk and need intensive management. • For other persons, risk estimation systems described in this chapter help to identify those with unexpectedly high or low risk and hence help to avoid undertreatment or overtreatment.

Chapter.  4697 words.  Illustrated.

Subjects: Cardiovascular Medicine

Full text: subscription required

How to subscribe Recommend to my Librarian

Buy this work at Oxford University Press »

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.